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Everolimus-Eluting Bioresorbable Vascular Scaffold Use in Acute Coronary
Syndromes: Initial Clinical Experience from South Western Canada
Ayyaz Sultan, Varinder Randhawa, Mistre Alemayehu, Shahar Lavi
London Health Sciences Centre, London, ON, Canada
BACKGROUND Contemporary studies have established encouraging clinical out-
comes for the everolimus-eluting bioresorbable vascular scaffold (BVS) ABSORB in
patients with stable coronary artery disease (CAD). There is limited data on its use in
patients presenting with acute coronary syndromes (ACS). We aimed to evaluate the
safety and efﬁcacy of BVS deployment in the setting of ACS at our tertiary cardiac
center in southwestern Ontario.
METHODS Retrospective chart review of all ACS with BVS use was undertaken since
June 2013. Data was analyzed for baseline demography and in-hospital and 30-day
mortality.
RESULTS 43 BVS were deployed in 30 patients. Mean age was 56.5+2.2 years; 30%
were female and 76.6% were less than 65 years old. Nearly 70% were hypertensive
and dyslipidemic, while one-third were diabetics and smokers. 50% of the patients
presented with STEMI, of which 86.7% received primary PCI. Mean total Syntax score
was 14.0+1.5 and 72.1% of lesions were ACC Type “B” lesions, with visible thrombus
present in one-third. Complete occlusion was seen in 18.6% of lesions at the outset.
62.8% were LAD lesions. All BVS were deployed in the ﬁrst attempt. 75% (33/43) of
BVS were post dilated. Final TIMI-3 ﬂow was evident in 42 (97.7%) patients, with no
case of worsening coronary ﬂow. 30% of all BVS were deployed across bifurcations
without any loss of coronary ﬂow in the side branches. There has been no reported
case of in-hospital or 30-day mortality, early stent thrombosis or repeat revasculari-
zation of the index artery.
CONCLUSIONS Our experience suggests that usage of BVS, in selected ’real-world’
patients with ACS, may be a safe and practical option with favorable short-term
outcomes. Long-term follow up data and further evaluation in larger randomized
controlled trials is needed.CRT-103
NSTEMI In Elderly Patients Treated With Early Revascularization: Long-term
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BACKGROUND Elderly patients represent a larger proportion of patients with Non-ST
elevation acute coronary syndrome (NSTEACS), but their management is still unclear.
Recent studies report a mortality rate up to 50% in elderly NSTEACS patients
conservatively treated. The aim of this study is to analyze the long term outcome of
elderly NSTEACS patients undergoing percutaneous coronary intervention (PCI).
METHODS Study population consisted of 452 consecutive patients (75.43.8 years)
admitted, from January 2003 to January 2004, at our Institution with diagnosis of
NSTEACS and underwent PCI. All clinical, angiographic and follow- up data were
collected and entered into a dedicated database. The primary endpoint was the
combined of death, acute myocardial infarction, re- PCI or the need forrevascularization surgery. Follow-up was conducted at our outpatient clinic or by
phone interview.
RESULTS The mean follow-up was 8.7  1.6 years (range 0-10 years). According
with age, study population was divided into three groups: group 1 (n¼278; age 70-
75 years), group 2 (n¼130; age 75-80 years), group 3 (n¼44; age>80 years). Patients
of group 3 showed a signiﬁcantly higher incidence of diabetes (40.9%) compared
with other groups (21.6% and 33.8%, p¼0.003), while no other differences in
clinical and angiographic features were observed. The overall mortality at long-
term follow-up was 22.8%. The in hospital mortality was 1.9%. Subgroup analysis
showed a signiﬁcantly higher mortality in group 3 (43.2%) compared to the other
groups (21.4% group 1 and 19.2% group 2; p¼0.003). Multivariate analysis identi-
ﬁed age (c¼5.2; OR¼1.06; 95% Cl: 1.00-1.11; p¼0.02) and male sex (c¼5.9; OR¼2.02;
95% Cl: 1.15-3.57; p¼0.015) as independent predictors of mortality in long term
outcome.
CONCLUSIONS In a consecutive series of elderly patients with NSTEACS, PCI is
associated with a low in hospital mortality rate and an improved event free survival at
10 years follow up.
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Association between Prolonged QTc Interval and Coronary Blood Flow to the
Infarct-related Artery in Patients With Non-ST Elevation Myocardial Infarction
Naoki Misumida, Akihiro Kobayahsi, John Fox, Yumiko Kanei
Mount Sinai Beth Israel, New York, NY
BACKGROUND Corrected QT (QTc) interval has been reported to prolong when the
myocardium is exposed to ischemia. However, little is known about the association
between prolonged QTc and coronary blood ﬂow to the infarct-related artery in the
setting of non-ST-elevation myocardial infarction (NSTEMI). We hypothesized that
prolonged QTc predicts impaired coronary blood ﬂow to the infarct-related artery in
patients with NSTEMI.
METHODS We performed a retrospective analysis of 481 consecutive patients with
NSTEMI who underwent coronary angiography within ﬁve days after presentation.
Patients with atrial ﬁbrillation, complete bundle branch block, paced rhythm,
electrolytes disturbance, history of coronary artery bypass grafting and those on
antiarrhythmic medication were excluded. Electrocardiography and coronary
angiography were reviewed by a blind fashion. The QT was measured manually
from the onset of QRS complex to the end of T wave, and QTc was calculated
using Bazett’s formula. QTc prolongation was deﬁned as QTc greater than 450ms
in men and 470ms in women. Baseline characteristics, electrocardiographic and
angiographic ﬁndings including Thrombolysis In Myocardial Infarction ﬂow grade
of the infarct-related artery were compared between patients with and without
prolonged QTc.
RESULTS Of the 340 patients included in the ﬁnal analysis, 130 patients (38.2%) had a
prolonged QTc interval. With respect to baseline characteristics, there was no sig-
niﬁcant difference between the two groups. There was no signiﬁcant difference in the
rate of TIMI grade 0/1 ﬂow (25.4% vs. 18.6%, p¼0.14) and prevalence of obstructive
coronary artery disease (76.9% vs. 75.2%, p¼0.72). Median QTc was 453 ms in patients
with TIMI 0/1 ﬂow and 449 ms in those with TIMI 2/3 ﬂow (p¼0.79). There was no
signiﬁcant difference in the rate of angiographic thrombus (p¼0.22), collateral cir-
culation to the infarct-related artery (p¼0.43) and in-hospital percutaneous or sur-
gical revascularization (p¼0.29) between patients with and without QTc
prolongation. The peak troponin I values were comparable between the two groups
(0.76 ng/mL vs. 0.62 ng/mL, p¼0.8).
CONCLUSION Prolonged QTc interval was observed in one-third of the NSTEMI pa-
tients in our cohort of patients. Contrary to our expectation, prolonged QTc did not
have a predictive value for impaired coronary ﬂow to the infarct-related artery in
patients with NSTEMI.ACUTE MYOCARDIAL INFARCTION
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BACKGROUND Primary PCI is the standard of care for those presenting with STEMI.
Trans-radial (TR) vascular access to perform PCI is superior to trans-femoral (TF)
access, mainly due to reduced bleeding, leading to overall mortality beneﬁt; patient
satisfaction remains very high. Limited skills, concerns with prolonged procedure
time, difﬁcult vascular anatomy, presence of cardiogenic shock (CS), previous CABG
and abnormal Allen’s test are limiting factors.
METHODS We are one of the tertiary cardiac centres in UK, and a default radial
centre. Since beginning of the 24/7 STEMI program, we have performed PPCI in 773
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did not perform Allen’s test in any patients, presence of pulse was enough to proceed.
We assessed in-hospital complications.
RESULTS Out of all patients, 94.6% patients underwent PPCI through TR-TU vascular
access (96.9% in those without CS and 77.8% of those with CS). We failed to proceed
TR only in 2 patients. Three patients had occluded radial artery after previous pro-
cedure, in whom we performed PCI through TU approach in same arm. Total of 8
patients had procedure performed through TU access .
For all patients, mean door to balloon time was 49.8 minutes (door to cathlab: 23.8
mins and cath-lab to balloon time: 25.9 mins); call to balloon time was 115.1 mins,
without any signiﬁcant difference between those with / without CS. Contrast volume,
radiation dose and ﬂuoroscopy time were no different between groups.
In-hospital mortality was 1.5% in those without cardiogenic shock and 23.9% in
those with cardiogenic shock. None of the patients who had PPCI through TR-TU
access had any vascular complication. Only 6 patients who had PPCI through TF had
localized bleeding, without need for blood transfusion.
CONCLUSIONS 1. Performing PPCI through TR-TU access is safe, even in those with
CS, previous CABG and occluded radial artery after previous PCI.
2. Allen’s test is not a prerequisite, and should not be a limiting factor.
3. Once operators are well trained, majority of patients can have intervention
performed through TR-TU access without any time delay in completion of successful
intervention.
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Endothelial Dysfunction is Not Associated With No-reﬂow During Primary PCI
Ayyaz Sultan, Mistre Alemayehu, Shahar Lavi
London Health Sciences Centre, London, ON, Canada
INTRODUCTION Coronary no-reﬂow during primary PCI is a predictor of poorer car-
diovascular outcome. Both endothelial dysfunction and no-reﬂow involves abnormal
vascular function and hemostasis. Therefore, our aim was to assess the association
between risk factors, endothelial dysfunction and no reﬂow during primary PCI.
METHODS Thirty consecutive patients with STEMI and normal ﬂow during primary
PCI were compared to 19 consecutive patients who had no reﬂow. All subjects un-
derwent assessment of endothelial function (reactive hyperemia index- RHI) within
48-72 h post PCI using the EndoPAT device.
RESULTS Age, sex, and frequency of hypertension were similar in both groups.
Smokers were less likely to have no-reﬂow (Table). Post PCI there was less ST-
segment resolution in the no-reﬂow group (48%þ7 vs 81%þ6; p¼0.001). Patients who
had no reﬂow had subsequently lower ejection fraction (39þ10 vs 47þ10; p¼0.015).
There was no difference in vascular function (RHI) between groups. (Figure)
CONCLUSION Systemic vascular function is not associated with coronary no reﬂow.CRT-107
Abbreviated versus Standard Eptiﬁbatide Infusion in ST Elevation Myocardial
Infarction- Outcomes and Predictors of Complications
Alireza Bagherli, Farrukh Hussain, Seeger Shen, Kerrett Wallace, Chris Haye,
Steve Promislow
University of Manitoba, Winnipeg, MB, Canada
BACKGROUND Glycoprotein IIb/IIIa inhibition has been a mainstay in acute
myocardial infarction intervention. Major bleeding is a predictor of adverse outcomes
in ST elevation myocardial infarction (STEMI).
OBJECTIVES To determine the safety and bleeding outcomes of abbreviated
compared to standard infusions of the glycoprotein IIb/IIIa inhibitor eptiﬁbatide in
the setting of primary PCI for STEMI.
METHODS We analyzed a retrospective cohort of 93 STEMI patients who received
abbreviated (<18 hours) infusion of eptiﬁbatide and compared them to 91 STEMI
patients with standard (18 hours) infusion in primary PCI, from June 2009 to June
2011, at a single cardiac centre. Detailed chart review of demographic and clinical
characteristics, times to intervention, complications, electrocardiographic (ECG)
ﬁndings, bleeding, ejection fraction (EF), and stent thrombosis data was performed.
Descriptive statistics were utilized to outline safety and efﬁcacy outcomes. A
p-value <0.05 was considered signiﬁcant.
RESULTS Therewas no signiﬁcant difference between the two groups in complications
including GI bleeding, hematoma larger than 5 cm, ﬁstula or pseudo-aneurysm, retro-
peritoneal hemorrhage (RPH) or hemoglobin drop more than 50 g/L. Closure devices
were deployedmore in abbreviated infusion (65%vs. 44%, p-value: 0.004). Therewas a
trend towards improved ST elevation resolution > 50% in standard infusion (78% vs.
66%, p-value: 0.06) and CK peaked higher in abbreviated infusion (2088.9 þ/- 1982 vs.
1565þ/- 1545, p-value; 0.05). There was no signiﬁcant difference in stent thrombosis or
EF (47.25% þ/- 9.46 vs. 49.4% þ/- 9.2 for abbreviated and standard infusion respec-
tively, p-value: 0.12). There was no signiﬁcant difference in transfusion (3% vs. 5% for
abbreviated and standard infusion respectively, p-value: 0.44) or death (3.2% vs. 1.1%
for abbreviated and standard infusion respectively, p-value: 0.37).
CONCLUSIONS Abbreviated duration glycoprotein IIb/IIIa inhibition may be a safe
and novel alternative to standard infusion during STEMI. Although there was no
signiﬁcant difference in bleeding or vascular complications between abbreviated and
standard infusion groups, along with a trend towards better ST resolution and lower
CK in standard infusion group, but there was no signiﬁcant difference in stent
thrombosis, EF or death between the two groups. Further large prospective ran-
domized controlled trials are indicated to study this approach to reduce bleeding in
this high risk population.
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Clinical Outcomes Of Drug-eluting Stents Implantation In Octogenarians:
Difference In ST- And Non-ST-segment Elevation Myocardial Infarction
Wenjie Tian, Rebecca Torguson, Hideaki Ota, Thibault Lhermusier, Sarkis Kiramijyan,
Marco De, Magalhaes Pereira, Nevin Baker, Ron Waksman
MedStar Washington Hospital Center, Washington, DC
BACKGROUND Little information was available regarding the clinical outcomes of
drug-eluting stents (DES) in octogenarians with acute myocardial infarction (AMI).
